Stock comparison
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NEOG is larger
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
Market value leader
NEOG
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
Revenue leader
NEOG
NNNN: $8.65M vs NEOG: $894.66M.
Profit leader
NNNN
NNNN: $6.40M vs NEOG: -$1.09B.
Margin leader
NNNN
NNNN: 74.1% vs NEOG: -122.1% net margin.
| Metric | NNNN | NEOG |
|---|---|---|
| Market cap | $1.50 B | $2.12 B |
| US-listed rank | #2355 | #2092 |
| Revenue (latest FY) | $8.65M | $894.66M |
| Net income (latest FY) | $6.40M | -$1.09B |
| Net margin | 74.1% | -122.1% |
| P/E (trailing FY) | 234.2x | - |
| SEC filings | 40 | 1,894 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
In their latest fiscal years, Anbio Biotechnology reported $8.65M in revenue while NEOGEN CORP reported $894.66M.
Full pages: Anbio Biotechnology and NEOGEN CORP, or browse the full rankings.